Dev Prasad
Stock Analyst at LUCID CAPITAL MARKETS
(0.08)
# 4,192
Out of 4,874 analysts
4
Total ratings
25%
Success rate
-40.74%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Dev Prasad
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRD Opus Genetics | Initiates: Buy | $5 | $0.97 | +415.36% | 1 | Jun 17, 2025 | |
| AVTX Avalo Therapeutics | Initiates: Buy | $24 | $4.79 | +401.04% | 1 | Dec 17, 2024 | |
| IBIO iBio, Inc. | Initiates: Buy | $6 | $0.73 | +721.92% | 1 | Dec 17, 2024 | |
| CALC CalciMedica | Initiates: Buy | $13 | $1.57 | +728.03% | 1 | Dec 17, 2024 |
Opus Genetics
Jun 17, 2025
Initiates: Buy
Price Target: $5
Current: $0.97
Upside: +415.36%
Avalo Therapeutics
Dec 17, 2024
Initiates: Buy
Price Target: $24
Current: $4.79
Upside: +401.04%
iBio, Inc.
Dec 17, 2024
Initiates: Buy
Price Target: $6
Current: $0.73
Upside: +721.92%
CalciMedica
Dec 17, 2024
Initiates: Buy
Price Target: $13
Current: $1.57
Upside: +728.03%